TXMD logo

TherapeuticsMD (TXMD) Cash From Financing

Annual CFF

$3.15 M
+$238.36 M+101.34%

December 31, 2023

Summary

Performance

1-Year Change

+101.34%

3-Year Change

-96.1%

5-Year Change

-98.06%

15-Year Change

-95.66%

TXMD Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.39%
TXMD annual cash flow from financing activities is higher than 43.39% of companies in Healthcare sector

High & Low

All-time High

$188.83 M
TXMD annual cash flow from financing activities is currently -98.33% below its historical high of $188.83 million

3-Year Low

-$235.21 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
TXMD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
TXMD next annual earnings announcement is scheduled for Mar 5, 2025

OtherTXMDcash flowmetrics:

Annual CFI

$0.00
TXMD annual cash flow from investing activities is $0.00

Annual CFO

-$23.08 M
TXMD annual cash flow from operations is -$23.08 million

Annual FCF

-$23.08 M
TXMD annual free cash flow is -$23.08 million

Annual CAPEX

-
TXMD annual capital expenditures value is unknown

Quarterly CFF

$0.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-100%

3-Year Change

-

5-Year Change

-

TXMD Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

45.62%
TXMD quarterly cash flow from financing activities is higher than 45.62% of companies in Healthcare sector

High & Low

All-time High

$136.96 M
TXMD quarterly cash flow from financing activities is currently -100.00% below its historical high of $136.96 million

3-Year Low

-$120.00 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TXMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
TXMD next earnings announcement is scheduled for Mar 5, 2025

OtherTXMDcash flowmetrics:

Quarterly CFI

-
TXMD quarterly cash flow from investing activities value is unknown

Quarterly CFO

-$71.00 K
TXMD quarterly cash flow from operations is -$71.00 thousand

Quarterly FCF

-$71.00 K
TXMD quarterly free cash flow is -$71.00 thousand

Quarterly CAPEX

-
TXMD quarterly capital expenditures value is unknown

TTM CFF

$2.00 M
+$1000.00+0.05%

September 30, 2024

Summary

Performance

3-Month Change

+0.05%

1-Year Change

-36.46%

3-Year Change

-

5-Year Change

-

TXMD TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.81%
TXMD TTM cash flow from financing activities is higher than 35.81% of companies in Healthcare sector

High & Low

All-time High

$237.55 M
TXMD TTM cash flow from financing activities is currently -99.16% below its historical high of $237.55 million

3-Year Low

-$235.21 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
TXMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
TXMD next earnings announcement is scheduled for Mar 5, 2025

OtherTXMDcash flowmetrics:

TTM CFI

-
TXMD TTM cash flow from investing activities value is unknown

TTM CFO

-$3.81 M
TXMD TTM cash flow from operations is -$3.81 million

TTM FCF

-$3.81 M
TXMD TTM free cash flow is -$3.81 million

TTM CAPEX

-
TXMD TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TXMD Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+101.3%-100.0%-36.5%
3 y3 years-96.1%--
5 y5 years-98.1%--

TXMD Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-97.6%+101.3%-100.0%+100.0%-98.5%+100.8%
5 y5-year-98.3%+101.3%-100.0%+100.0%-99.2%+100.8%
alltimeall time-98.3%+101.3%-100.0%+100.0%-99.2%+100.8%

TherapeuticsMD Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
$2.00 M(+0.0%)
Jun 2024
-
$0.00(-100.0%)
$2.00 M(-36.5%)
Dec 2023
$3.15 M(-101.3%)
$2.00 M(<-9900.0%)
$3.15 M(-102.8%)
Sep 2023
-
-$1000.00(-100.1%)
-$110.80 M(+1.6%)
Jun 2023
-
$1.15 M(-101.0%)
-$109.06 M(-53.6%)
Dec 2022
-$235.21 M(-281.6%)
-$111.94 M(-6537.3%)
-$235.21 M(+92.9%)
Sep 2022
-
$1.74 M(-101.4%)
-$121.91 M(+32.8%)
Jun 2022
-
-$120.00 M(+2300.0%)
-$91.83 M(-421.0%)
Mar 2022
-
-$5.00 M(-469.5%)
$28.60 M(-77.9%)
Dec 2021
$129.55 M(+60.5%)
$1.35 M(-95.7%)
$129.55 M(-19.0%)
Sep 2021
-
$31.82 M(+7335.0%)
$159.90 M(+24.7%)
Jun 2021
-
$428.00 K(-99.6%)
$128.19 M(+0.3%)
Mar 2021
-
$95.95 M(+202.6%)
$127.85 M(+58.4%)
Dec 2020
$80.72 M(-57.2%)
$31.70 M(>+9900.0%)
$80.72 M(-36.0%)
Sep 2020
-
$106.00 K(+12.8%)
$126.05 M(+0.1%)
Jun 2020
-
$94.00 K(-99.8%)
$125.96 M(-47.0%)
Mar 2020
-
$48.82 M(-36.6%)
$237.55 M(+25.8%)
Dec 2019
$188.83 M(+16.0%)
$77.03 M(>+9900.0%)
$188.83 M(+68.3%)
Sep 2019
-
$8500.00(-100.0%)
$112.23 M(-44.5%)
Jun 2019
-
$111.69 M(>+9900.0%)
$202.23 M(+24.2%)
Mar 2019
-
$100.10 K(-76.7%)
$162.84 M(+0.0%)
Dec 2018
$162.79 M(+124.3%)
$429.90 K(-99.5%)
$162.79 M(+0.3%)
Sep 2018
-
$90.02 M(+24.5%)
$162.36 M(+15.2%)
Jun 2018
-
$72.30 M(>+9900.0%)
$140.91 M(+101.4%)
Mar 2018
-
$44.10 K(>+9900.0%)
$69.98 M(-3.6%)
Dec 2017
$72.58 M(-47.1%)
$0.00(-100.0%)
$72.58 M(-0.0%)
Sep 2017
-
$68.57 M(+4945.8%)
$72.59 M(+1704.8%)
Jun 2017
-
$1.36 M(-48.8%)
$4.02 M(+37.8%)
Mar 2017
-
$2.65 M(>+9900.0%)
$2.92 M(-97.9%)
Dec 2016
$137.23 M(+47.6%)
$10.00 K(+900.0%)
$137.23 M(-0.5%)
Sep 2016
-
$1000.00(-99.6%)
$137.86 M(-19.0%)
Jun 2016
-
$254.60 K(-99.8%)
$170.21 M(-0.1%)
Mar 2016
-
$136.96 M(>+9900.0%)
$170.45 M(+83.3%)
Dec 2015
$92.97 M(+114.7%)
$642.80 K(-98.0%)
$92.97 M(+0.7%)
Sep 2015
-
$32.36 M(+6480.3%)
$92.36 M(-10.2%)
Jun 2015
-
$491.70 K(-99.2%)
$102.90 M(+0.2%)
Mar 2015
-
$59.48 M(>+9900.0%)
$102.74 M(+137.3%)
Dec 2014
$43.30 M(-41.5%)
$30.20 K(-99.9%)
$43.30 M(+0.8%)
Sep 2014
-
$42.89 M(>+9900.0%)
$42.96 M(+40.7%)
Jun 2014
-
$334.20 K(+733.4%)
$30.54 M(-8.0%)
Mar 2014
-
$40.10 K(-112.9%)
$33.19 M(-55.1%)
Dec 2013
$73.99 M(+412.5%)
-$309.90 K(-101.0%)
$73.99 M(-7.3%)
Sep 2013
-
$30.47 M(+919.8%)
$79.82 M(+55.6%)
Jun 2013
-
$2.99 M(-92.7%)
$51.30 M(-2.7%)
Mar 2013
-
$40.84 M(+639.7%)
$52.71 M(+265.1%)
Dec 2012
$14.44 M(+206.7%)
$5.52 M(+183.1%)
$14.44 M(+34.0%)
Sep 2012
-
$1.95 M(-55.7%)
$10.77 M(+5.9%)
Jun 2012
-
$4.40 M(+71.5%)
$10.17 M(+47.3%)
Mar 2012
-
$2.57 M(+38.2%)
$6.91 M(+46.7%)
Dec 2011
$4.71 M(+48.5%)
$1.86 M(+37.7%)
$4.71 M(-28.4%)
Sep 2011
-
$1.35 M(+18.5%)
$6.57 M(+50.2%)
Jun 2011
-
$1.14 M(+209.7%)
$4.38 M(+31.1%)
Mar 2011
-
$367.20 K(-90.1%)
$3.34 M(+5.3%)
DateAnnualQuarterlyTTM
Dec 2010
$3.17 M(+143.8%)
$3.72 M(-537.7%)
$3.17 M(-1368.2%)
Sep 2010
-
-$850.00 K(-950.0%)
-$250.00 K(-115.6%)
Jun 2010
-
$100.00 K(-50.0%)
$1.60 M(+6.7%)
Mar 2010
-
$200.00 K(-33.3%)
$1.50 M(+15.4%)
Dec 2009
$1.30 M(-688.0%)
$300.00 K(-70.0%)
$1.30 M(+30.0%)
Sep 2009
-
$1.00 M(>+9900.0%)
$1.00 M(>+9900.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2009
-
$0.00(0.0%)
-$181.40 K(-18.0%)
Dec 2008
-$221.20 K(-76.6%)
$0.00(0.0%)
-$221.20 K(-81.0%)
Sep 2008
-
$0.00(-100.0%)
-$1.17 M(0.0%)
Jun 2008
-
-$181.40 K(+355.8%)
-$1.17 M(+18.4%)
Mar 2008
-
-$39.80 K(-95.8%)
-$983.70 K(+4.2%)
Dec 2007
-$943.90 K(+214.0%)
-$943.90 K(<-9900.0%)
-$943.90 K(<-9900.0%)
Sep 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2006
-$300.60 K(-200.0%)
$0.00(0.0%)
-$300.60 K(<-9900.0%)
Sep 2006
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2006
-
$0.00(-100.0%)
$0.00(0.0%)
Mar 2006
-
-$300.60 K(-200.0%)
$0.00(-100.0%)
Dec 2005
$300.60 K(>+9900.0%)
$300.60 K(>+9900.0%)
$300.60 K(>+9900.0%)
Sep 2005
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2005
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2004
-
$0.00(0.0%)
-$10.60 K(+1666.7%)
Jun 2004
-
$0.00(0.0%)
-$600.00(-113.6%)
Mar 2004
-
$0.00(-100.0%)
$4400.00(-56.0%)
Dec 2003
$10.00 K(-66.7%)
-$10.60 K(-206.0%)
$10.00 K(-80.2%)
Sep 2003
-
$10.00 K(+100.0%)
$50.60 K(+24.6%)
Jun 2003
-
$5000.00(-10.7%)
$40.60 K(+14.0%)
Mar 2003
-
$5600.00(-81.3%)
$35.60 K(+18.7%)
Dec 2002
$30.00 K(<-9900.0%)
$30.00 K(>+9900.0%)
$30.00 K(>+9900.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2001
-$200.00(+100.0%)
$0.00(0.0%)
-$200.00(0.0%)
Sep 2001
-
$0.00(0.0%)
-$200.00(-33.3%)
Jun 2001
-
$0.00(-100.0%)
-$300.00(0.0%)
Mar 2001
-
-$200.00(<-9900.0%)
-$300.00(+200.0%)
Dec 2000
-$100.00(-99.3%)
$0.00(-100.0%)
-$100.00(-99.6%)
Sep 2000
-
-$100.00(<-9900.0%)
-$23.70 K(-341.8%)
Jun 2000
-
$0.00(0.0%)
$9800.00(0.0%)
Mar 2000
-
$0.00(-100.0%)
$9800.00(-172.1%)
Dec 1999
-$13.60 K(+1600.0%)
-$23.60 K(-170.7%)
-$13.60 K(-236.0%)
Sep 1999
-
$33.40 K(>+9900.0%)
$10.00 K(-142.7%)
Jun 1999
-
$0.00(-100.0%)
-$23.40 K(0.0%)
Mar 1999
-
-$23.40 K
-$23.40 K
Dec 1998
-$800.00(+166.7%)
-
-
Dec 1997
-$300.00(-99.4%)
-
-
Dec 1996
-$53.40 K(-232.8%)
-
-
Dec 1995
$40.20 K(>+9900.0%)
-
-
Dec 1994
$0.00(-100.0%)
-
-
Dec 1993
-$100.00
-
-

FAQ

  • What is TherapeuticsMD annual cash flow from financing activities?
  • What is the all time high annual CFF for TherapeuticsMD?
  • What is TherapeuticsMD annual CFF year-on-year change?
  • What is TherapeuticsMD quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for TherapeuticsMD?
  • What is TherapeuticsMD quarterly CFF year-on-year change?
  • What is TherapeuticsMD TTM cash flow from financing activities?
  • What is the all time high TTM CFF for TherapeuticsMD?
  • What is TherapeuticsMD TTM CFF year-on-year change?

What is TherapeuticsMD annual cash flow from financing activities?

The current annual CFF of TXMD is $3.15 M

What is the all time high annual CFF for TherapeuticsMD?

TherapeuticsMD all-time high annual cash flow from financing activities is $188.83 M

What is TherapeuticsMD annual CFF year-on-year change?

Over the past year, TXMD annual cash flow from financing activities has changed by +$238.36 M (+101.34%)

What is TherapeuticsMD quarterly cash flow from financing activities?

The current quarterly CFF of TXMD is $0.00

What is the all time high quarterly CFF for TherapeuticsMD?

TherapeuticsMD all-time high quarterly cash flow from financing activities is $136.96 M

What is TherapeuticsMD quarterly CFF year-on-year change?

Over the past year, TXMD quarterly cash flow from financing activities has changed by -$2.00 M (-100.00%)

What is TherapeuticsMD TTM cash flow from financing activities?

The current TTM CFF of TXMD is $2.00 M

What is the all time high TTM CFF for TherapeuticsMD?

TherapeuticsMD all-time high TTM cash flow from financing activities is $237.55 M

What is TherapeuticsMD TTM CFF year-on-year change?

Over the past year, TXMD TTM cash flow from financing activities has changed by -$1.15 M (-36.46%)